A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg

PHASE3CompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

August 31, 2014

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Zabofloxacin

Zabofloxacin 367mg tablet P.O. once daily for 5days and then Placebo P.O. once daily for 2days

DRUG

Moxifloxacin

Moxifloxacin 400mg tablet P.O. once daily for 7days

Trial Locations (1)

Unknown

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Chonbuk National University Hospital

OTHER

collaborator

Chosun University Hospital

OTHER

collaborator

Bundang CHA Hospital

OTHER

collaborator

Chungbuk National University

OTHER

collaborator

Kangdong Sacred Heart Hospital

OTHER

collaborator

Hanyang University

OTHER

collaborator

Asan Medical Center

OTHER

collaborator

Gachon University Gil Medical Center

OTHER

collaborator

The Catholic University of Korea

OTHER

collaborator

Konyang University Hospital

OTHER

collaborator

KangWon National University Hospital

OTHER

collaborator

Gyeongsang National University Hospital

OTHER

collaborator

Kyunghee University Medical Center

OTHER

collaborator

Korea University Anam Hospital

OTHER

collaborator

DongGuk University

OTHER

collaborator

Severance Hospital

OTHER

collaborator

Yeungnam University Hospital

OTHER

collaborator

Ulsan University Hospital

OTHER

collaborator

Ewha Womans University Mokdong Hospital

OTHER

collaborator

Inje University

OTHER

collaborator

Chonnam National University Hospital

OTHER

collaborator

Catholic University of Korea Saint Paul's Hospital

OTHER

collaborator

Incheon St.Mary's Hospital

OTHER

collaborator

Masan Samsung Hospital, South Korea

OTHER

collaborator

Konkuk University Medical Center

OTHER

collaborator

Keimyung University Dongsan Medical Center

OTHER

collaborator

Wonju Severance Christian Hospital

OTHER

collaborator

Hallym University Medical Center

OTHER

collaborator

Ajou University

OTHER

collaborator

Chungnam National University Hospital

OTHER

lead

Dong Wha Pharmaceutical Co. Ltd.

INDUSTRY